| 中國醫藥大學 |
2016-01 |
Oral Citrulline Mitigates Inflammation and Jejunal Damage via the Inactivation of Neuronal Nitric Oxide Synthase and Nuclear Factor–κB in Intestinal Ischemia and Reperfusion
|
(Chun-Hong Lai);李建興(Chien-Hsin Lee);(Ching-Yi Hung);(Hui-Chen Lo)* |
| 國立臺灣大學 |
2003 |
Oral Clodronate Therapy for Hypercalcemia Related to Extensive Subcutaneous Fat Necrosis in a Newborn
|
洪碩壎; 蔡文友; 曹伯年; 周弘傑; 謝武勳; HUNG, SHUO-HSUN; TSAI, WEN-YU; TSAO, PO- NIEN; CHOU, HUNG-CHIEH; HSIEH, WU-SHIUN |
| 臺大學術典藏 |
2018-09-10T04:25:26Z |
Oral clodronate therapy for hypercalcemia related to extensive subcutaneous fat necrosis in a newborn
|
Hung, S.-H.;Tsai, W.-Y.;Tsao, P.-N.;Chou, H.-C.;Hsieh, W.-S.; WEN-YU TSAI |
| 臺大學術典藏 |
2018-09-10T04:38:14Z |
Oral clodronate therapy for hypercalcemia related to extensive subcutaneous fat necrosis in a newborn
|
Hung, S.-H.;Tsai, W.-Y.;Tsao, P.-N.;Chou, H.-C.;Hsieh, W.-S.; WU-SHIUN HSIEH |
| 臺大學術典藏 |
2020-12-22T03:29:51Z |
Oral clodronate therapy for hypercalcemia related to extensive subcutaneous fat necrosis in a newborn
|
Tsai W.-Y.; Hung S.-H.; Hung S.-H.;Tsai W.-Y.;Po-Nien Tsao;Chou H.-C.;Hsieh W.-S.; PO-NIEN TSAO; Chou H.-C.; Hsieh W.-S. |
| 臺大學術典藏 |
2020-12-24T02:04:10Z |
Oral clodronate therapy for hypercalcemia related to extensive subcutaneous fat necrosis in a newborn
|
Hsieh W.-S.; HUNG-CHIEH CHOU; Tsai W.-Y.; Tsao P.-N.; Hung S.-H.; Hung S.-H.;Tsai W.-Y.;Tsao P.-N.;Hung-Chieh Chou;Hsieh W.-S. |
| 國立臺灣大學 |
1990 |
Oral Complications Associated with Endotracheal General Anesthesia
|
Chen, Jaw-Jen; Luciana, Susetio; 趙繼慶; Chen, Jaw-Jen; Luciana, Susetio; Chao, Chi-Ching |
| 國立臺灣大學 |
1998 |
ORAL CONTRACEPTIVES AND BREAST CANCER RISK IN TAIWAN, A COUNTRY OF LOW INCIDENCE OF BREAST CANCER AND LOW USE OF ORAL CONTRACEPTIVES
|
CHIE, WEI-CHU; LI, CHUNG-YI; HUANG, CHIUN-SHENG; YEN, MENG-LUH; CHANG, KING-JEN; LIN, RUE-SHEN; 季瑋珠; 李中一; 黃俊升; 嚴孟祿; 張金堅; 林瑞雄 |
| 臺大學術典藏 |
2018-09-10T06:49:08Z |
Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives
|
Chie, W.-C.;Li, C.-Y.;Huang, C.-S.;Chang, K.-J.;Yen, M.-L.;Lin, R.-S.; MEN-LUH YEN; WEI-CHU CHIE |
| 臺大學術典藏 |
2018-09-10T07:12:47Z |
Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives
|
Chie, W.-C.; Li, C.-Y.; Huang, C.-S.; Chang, K.-J.; Yen, M.-L.; Lin, R.-S.; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2020-02-11T01:34:22Z |
Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives
|
MEN-LUH YEN;Lin R.-S.;Chang K.-J;Huang C.-S;Li C.-Y;Chie W.-C; Chie W.-C; Li C.-Y; Huang C.-S; Chang K.-J; MEN-LUH YEN; Lin R.-S. |
| 臺大學術典藏 |
2020-02-11T01:44:00Z |
Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives
|
Lin R.-S.;MEN-LUH YEN;Chang K.-J;Huang C.-S;Li C.-Y;Chie W.-C; Chie W.-C; Li C.-Y; Huang C.-S; Chang K.-J; MEN-LUH YEN; Lin R.-S. |
| 臺大學術典藏 |
1998 |
Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives
|
Lin R.-S.; Yen M.-L.; Chang K.-J.; Li C.-Y.; CHIUN-SHENG HUANG; Chie W.-C.; Lin R.-S.;Yen M.-L.;Chang K.-J.;CHIUN-SHENG HUANG;Li C.-Y.;Chie W.-C. |
| 臺大學術典藏 |
2022-05-05T09:10:42Z |
Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives
|
WEI-CHU CHIE; Li C.-Y.; Huang C.-S.; Chang K.-J.; Yen M.-L.; Lin R.-S. |
| 臺大學術典藏 |
2022-08-12T06:29:05Z |
Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives
|
Chie W.-C.; Li C.-Y.; Huang C.-S.; KING-JEN CHANG; Yen M.-L.; Lin R.-S. |
| 臺大學術典藏 |
2022-05-14T23:35:19Z |
Oral Conventional Synthetic Disease-Modifying Antirheumatic Drugs with Antineoplastic Potential: a Review
|
Hsieh, Cho Hsun; Huang, Yi Wei; TSEN-FANG TSAI |
| 臺大學術典藏 |
2022-09-20T06:06:16Z |
Oral Conventional Synthetic Disease-Modifying Antirheumatic Drugs with Antineoplastic Potential: a Review
|
Hsieh, Cho-Hsun; Huang, Yi-Wei; TSEN-FANG TSAI |
| 輔英科技大學 |
2013-03-01 |
Oral Corrective Feedback---Impolicit or Explicit?
|
胡娟暐 |
| 輔英科技大學 |
2013-03-08 |
Oral Corrective Feedback--Implicit or Explicit?
|
魏孟雪 |
| 國立成功大學 |
2021 |
Oral corticosteroid bursts and severe adverse events: a critical appraisal
|
Shao, Shao S.-C.;Kuo, L.-T.;Lai, E.C.C.;Chi, Chi C.-C. |
| 臺大學術典藏 |
2017 |
Oral delivery of dsRNA lipoplexes to German cockroach protects dsRNA from degradation and induces RNAi response
|
Lin Y.-H.; Huang J.-H.; Liu Y.; Belles X.; Lee H.-J.; HOW-JING LEE |
| 國家衛生研究院 |
2008-06 |
Oral delivery of peptide drugs using nanoparticles self-assembled by poly(gamma-glutamic acid) and a chitosan derivative functionalized by trimethylation
|
Mi, FL; Wu, YY; Lin, YH; Sonaje, K; Ho, YC; Chen, CT; Juang, JH; Sung, HW |
| 中國醫藥大學 |
2008.06 |
Oral Delivery of Peptide Drugs Using Nanoparticles Self-Assembled by Poly(γ-glutamic acid) and a Chitosan Derivative Functionalized by Trimethylation
|
糜福隆(Fwu-Long Mi); 吳勇毅(Yong-Yi Wu); 林宥欣(Yu-Hsin. Lin); (Kiran Sonaje); (Yi-Cheng Ho); 陳炯東(Chiung-Tong Chen); 莊峻鍠(Jyuhn-Huarng Juang); 宋信文(Hsing-Wen Sung)* |
| 國立成功大學 |
2022-02 |
Oral dexamethasone for COVID-19 patients at the initial recognition of hypoxia: Can an early dose herald a better outcome?
|
Lo, Ching-Lung;Syue, Ling-Shan;Ko, Wen-Chien |
| 中山醫學大學 |
2017-06 |
Oral Direct Acting Antivirals treatment failed to cure a patient with chronic hepatitis C due to shifts of viral genotype
|
Lee, Shou-Wu;Yang, Sheng-Shun;Lee, Teng-Yu;Yeh, Hong-Zen;Lu, I-Ta;Chang, Chi-Sen |
